Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)
AstraZeneca
Jonathan E Rosenberg; Se Hoon Park; Vadim Kozlov; Tu V Dao; Daniel Castellano; Jian-Ri Li; Som D Mukherjee; Kathryn Howells; Hannah Dry; Mark C Lanasa; Ross Stewart; Dean F Bajorin